Ali A. Rizvi

TitleCLINICAL PROFESSOR-USC
InstitutionUniversity of South Carolina School of Medicine
DepartmentMDC INTERNAL MEDICINE
Address5 MEDICAL PARK
Columbia, South Carolina 29203
Phone(803)545-5342
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Popovic DS, Papanas N, Koufakis T, Kotsa K, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kempler P, Kapoor N, Lessan N, Lotufo P, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M. Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert Panel. Exp Clin Endocrinol Diabetes. 2023 Mar 08. PMID: 36693416.
      Citations: 1     Fields:    
    2. Giglio RV, Patti AM, Rizvi AA, Stoian AP, Ciaccio M, Papanas N, Janez A, Sonmez A, Banach M, Sahebkar A, Rizzo M. Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update. Biomedicines. 2023 Jan 20; 11(2). PMID: 36830828; PMCID: PMC9953496.
      Citations:    
    3. Mainas G, Nibali L, Ide M, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Jane? A, Kalra S, Kapoor N, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M, CArdiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO). Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence. Metabolites. 2022 Dec 26; 13(1). PMID: 36676965.
      Citations:    
    4. Giglio RV, Papanas N, Rizvi AA, Ciaccio M, Patti AM, Ilias I, Pantea Stoian A, Sahebkar A, Janez A, Rizzo M. An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes. Medicina (Kaunas). 2022 Oct 17; 58(10). PMID: 36295635; PMCID: PMC9609741.
      Citations:    Fields:    Translation:Humans
    5. Rizvi AA, Kathuria A, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Galia M, Goh SY, Janez A, Kalra S, Kempler P, Lessan N, Lotufo P, Papanas N, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M, CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). Post-COVID syndrome, inflammation, and diabetes. J Diabetes Complications. 2022 11; 36(11):108336. PMID: 36228563; PMCID: PMC9534783.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    6. Lo Presti E, Nuzzo D, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kapoor N, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M, CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health. Biochim Biophys Acta Mol Basis Dis. 2022 12 01; 1868(12):166559. PMID: 36174875; PMCID: PMC9510069.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    7. Kapoor N, Kalra S, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M, CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact. Diabetes Ther. 2022 Oct; 13(10):1723-1736. PMID: 36030317; PMCID: PMC9419639.
      Citations: 1     
    8. Rizvi AA, Popovic DS, Papanas N, Pantea Stoian A, Al Mahmeed W, Sahebkar A, Janez A, Rizzo M, Rizvi AA, Popovic DS, Papanas N, Pantea Stoian A, Al Mahmeed W, Sahebkar A, Janez A, Rizzo M. Current and emerging drugs for the treatment of atherosclerosis: the evidence to date. Expert Rev Cardiovasc Ther. 2022 Jul; 20(7):515-527. PMID: 35786159.
      Citations: 1     Fields:    Translation:Humans
    9. Jensterle M, Herman R, Janež A, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Galia M, Goh SY, Kalra S, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M, Jensterle M, Herman R, Jane? A, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Galia M, Goh SY, Kalra S, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M. The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel. Int J Mol Sci. 2022 Jun 30; 23(13). PMID: 35806331; PMCID: PMC9266848.
      Citations: 7     Fields:    Translation:HumansCells
    10. Rizvi AA, Rizzo M, Rizvi AA, Rizzo M. The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction. Diabetes Metab Syndr Obes. 2022; 15:1023-1030. PMID: 35411165; PMCID: PMC8994606.
      Citations: 5     
    11. Rizvi AA, Linhart A, Vrablik M, Liberopoulos E, Rizzo M, Rizvi AA, Linhart A, Vrablik M, Liberopoulos E, Rizzo M. Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections. Expert Opin Drug Saf. 2022 03; 21(3):291-293. PMID: 35188012.
      Citations:    
    12. Nikolic D, Patti AM, Giglio RV, Chianetta R, Castellino G, Magán-Fernández A, Citarrella R, Papanas N, Janez A, Stoian AP, Rizvi AA, Rizzo M, Nikolic D, Patti AM, Giglio RV, Chianetta R, Castellino G, Mag?n-Fern?ndez A, Citarrella R, Papanas N, Janez A, Stoian AP, Rizvi AA, Rizzo M. Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study. Diabetes Ther. 2022 Mar; 13(3):453-464. PMID: 35167051; PMCID: PMC8853434.
      Citations:    
    13. Popoviciu MS, Marin VN, Vesa CM, Stefan SD, Stoica RA, Serafinceanu C, Merlo EM, Rizvi AA, Rizzo M, Busnatu S, Stoian AP, Popoviciu MS, Marin VN, Vesa CM, Stefan SD, Stoica RA, Serafinceanu C, Merlo EM, Rizvi AA, Rizzo M, Busnatu S, Stoian AP. Correlations between Diabetes Mellitus Self-Care Activities and Glycaemic Control in the Adult Population: A Cross-Sectional Study. Healthcare (Basel). 2022 Jan 17; 10(1). PMID: 35052337; PMCID: PMC8775516.
      Citations:    
    14. Patti AM, Giglio RV, Papanas N, Serban D, Stoian AP, Pafili K, Al Rasadi K, Rajagopalan K, Rizvi AA, Ciaccio M, Rizzo M, Patti AM, Giglio RV, Papanas N, Serban D, Stoian AP, Pafili K, Al Rasadi K, Rajagopalan K, Rizvi AA, Ciaccio M, Rizzo M. Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes. Medicina (Kaunas). 2022 Jan 11; 58(1). PMID: 35056417; PMCID: PMC8779029.
      Citations:    
    15. Dascalu AM, Rizzo M, Rizvi AA, Stoian AP, Iancu RC, Stana D, Tudosie MS, Serban D, Dascalu AM, Rizzo M, Rizvi AA, Stoian AP, Iancu RC, Stana D, Tudosie MS, Serban D. Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema - A Systematic Review. Curr Pharm Des. 2022; 28(21):1758-1768. PMID: 35469564.
      Citations: 1     Fields:    Translation:Humans
    16. Stoian AP, Kempler P, Stulnig T, Rizvi AA, Rizzo M, Stoian AP, Kempler P, Stulnig T, Rizvi AA, Rizzo M. Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us. Metab Syndr Relat Disord. 2022 04; 20(3):137-140. PMID: 34967689.
      Citations:    
    17. Al Mahmeed W, Al-Rasadi K, Banerjee Y, Ceriello A, Cosentino F, Galia M, Goh SY, Kempler P, Lessan N, Papanas N, Rizvi AA, Santos RD, Stoian AP, Toth PP, Rizzo M, Al Mahmeed W, Al-Rasadi K, Banerjee Y, Ceriello A, Cosentino F, Galia M, Goh SY, Kempler P, Lessan N, Papanas N, Rizvi AA, Santos RD, Stoian AP, Toth PP, Rizzo M, CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel. Front Cardiovasc Med. 2021; 8:787761. PMID: 34977193; PMCID: PMC8715947.
      Citations:    
    18. Serban D, Papanas N, Dascalu AM, Kempler P, Raz I, Rizvi AA, Rizzo M, Tudor C, Silviu Tudosie M, Tanasescu D, Pantea Stoian A, Gouveri E, Ovidiu Costea D, Serban D, Papanas N, Dascalu AM, Kempler P, Raz I, Rizvi AA, Rizzo M, Tudor C, Silviu Tudosie M, Tanasescu D, Pantea Stoian A, Gouveri E, Ovidiu Costea D. Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets. Int J Low Extrem Wounds. 2021 Nov 18; 15347346211057742. PMID: 34791913.
      Citations:    
    19. Rizvi AA, Janez A, Rizzo M, Rizvi AA, Janez A, Rizzo M. Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues. Int J Mol Sci. 2021 Nov 15; 22(22). PMID: 34830193; PMCID: PMC8619040.
      Citations:    
    20. Ceriello A, Rizvi AA, Rizzo M, Ceriello A, Rizvi AA, Rizzo M. Glycemic Variability, Glycated Hemoglobin, and Cardiovascular Complications: Still a Dilemma in Clinical Practice. Adv Ther. 2022 01; 39(1):1-4. PMID: 34757599.
      Citations:    
    21. Rizvi AA, Stoian AP, Janez A, Rizzo M, Rizvi AA, Stoian AP, Janez A, Rizzo M. Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options. Biomedicines. 2021 Oct 29; 9(11). PMID: 34829807; PMCID: PMC8615620.
      Citations:    
    22. Popovic DS, Papanas N, Pantea Stoian A, Rizvi AA, Janez A, Rizzo M, Popovic DS, Papanas N, Pantea Stoian A, Rizvi AA, Janez A, Rizzo M. Use of Novel Antidiabetic Agents in Patients with Type?2 Diabetes and COVID-19: A Critical Review. Diabetes Ther. 2021 Dec; 12(12):3037-3054. PMID: 34699021; PMCID: PMC8546380.
      Citations:    
    23. Banerjee Y, Pantea Stoian A, Cicero AFG, Fogacci F, Nikolic D, Sachinidis A, Rizvi AA, Janez A, Rizzo M, Banerjee Y, Pantea Stoian A, Cicero AFG, Fogacci F, Nikolic D, Sachinidis A, Rizvi AA, Janez A, Rizzo M. Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia. Expert Opin Drug Saf. 2022 Jan; 21(1):9-20. PMID: 34596005.
      Citations:    
    24. Rizvi AA, Stoian AP, Rizzo M, Rizvi AA, Stoian AP, Rizzo M. Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies. Int J Mol Sci. 2021 Sep 17; 22(18). PMID: 34576200; PMCID: PMC8470871.
      Citations:    
    25. Shahzadi SK, Naidoo N, Alsheikh-Ali A, Rizzo M, Rizvi AA, Santos RD, Banerjee Y, Shahzadi SK, Naidoo N, Alsheikh-Ali A, Rizzo M, Rizvi AA, Santos RD, Banerjee Y. Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review. Int J Mol Sci. 2021 Aug 29; 22(17). PMID: 34502285; PMCID: PMC8430576.
      Citations:    
    26. Banerjee Y, Pantea Stoian A, Silva-Nunes J, Sonmez A, Rizvi AA, Janez A, Rizzo M, Banerjee Y, Pantea Stoian A, Silva-Nunes J, Sonmez A, Rizvi AA, Janez A, Rizzo M. The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism. Expert Opin Drug Saf. 2021 Nov; 20(11):1309-1315. PMID: 34424130; PMCID: PMC8425441.
      Citations:    
    27. Rizvi AA, Stoian AP, Lessan N, Rizzo M, Rizvi AA, Stoian AP, Lessan N, Rizzo M. Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care. Medicina (Kaunas). 2021 Aug 06; 57(8). PMID: 34441011; PMCID: PMC8399077.
      Citations:    
    28. Rizvi AA, Janez A, Al Mahmeed W, Rizzo M, Rizvi AA, Janez A, Al Mahmeed W, Rizzo M. Diabetes and COVID-19: A Tale of 2 Pandemics. J Cardiovasc Pharmacol. 2021 07 01; 78(1):e1-e2. PMID: 34173808; PMCID: PMC8253376.
      Citations:    
    29. Dogru T, Kirik A, Gurel H, Rizvi AA, Rizzo M, Sonmez A, Dogru T, Kirik A, Gurel H, Rizvi AA, Rizzo M, Sonmez A. The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart. Int J Mol Sci. 2021 Jun 21; 22(12). PMID: 34205674; PMCID: PMC8234007.
      Citations:    
    30. Giglio RV, Pantea Stoian A, Al-Rasadi K, Banach M, Patti AM, Ciaccio M, Rizvi AA, Rizzo M, Giglio RV, Pantea Stoian A, Al-Rasadi K, Banach M, Patti AM, Ciaccio M, Rizvi AA, Rizzo M. Novel Therapeutical Approaches to Managing Atherosclerotic Risk. Int J Mol Sci. 2021 Apr 28; 22(9). PMID: 33924893; PMCID: PMC8125277.
      Citations:    
    31. Giglio RV, Stoian AP, Haluzik M, Pafili K, Patti AM, Rizvi AA, Ciaccio M, Papanas N, Rizzo M, Giglio RV, Stoian AP, Haluzik M, Pafili K, Patti AM, Rizvi AA, Ciaccio M, Papanas N, Rizzo M. Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus. Biochim Biophys Acta Mol Basis Dis. 2021 08 01; 1867(8):166148. PMID: 33892081.
      Citations:    
    32. Giglio RV, Stoian AP, Patti AM, Rizvi AA, Sukhorukov V, Ciaccio M, Orekhov A, Rizzo M, Giglio RV, Stoian AP, Patti AM, Rizvi AA, Sukhorukov V, Ciaccio M, Orekhov A, Rizzo M. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome. Curr Pharm Des. 2021; 27(35):3729-3740. PMID: 33845722.
      Citations:    
    33. Nikolic D, Giglio RV, Rizvi AA, Patti AM, Montalto G, Maranta F, Cianflone D, Stoian AP, Rizzo M, Nikolic D, Giglio RV, Rizvi AA, Patti AM, Montalto G, Maranta F, Cianflone D, Stoian AP, Rizzo M. Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect. Diabetes Ther. 2021 Jan; 12(1):261-274. PMID: 33210276; PMCID: PMC7843804.
      Citations:    
    34. Giglio RV, Carruba G, Cicero AFG, Banach M, Patti AM, Nikolic D, Cocciadiferro L, Zarcone M, Montalto G, Stoian AP, Banerjee Y, Rizvi AA, Toth PP, Rizzo M, Giglio RV, Carruba G, Cicero AFG, Banach M, Patti AM, Nikolic D, Cocciadiferro L, Zarcone M, Montalto G, Stoian AP, Banerjee Y, Rizvi AA, Toth PP, Rizzo M. Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study. Metabolites. 2020 Oct 26; 10(11). PMID: 33114614; PMCID: PMC7694062.
      Citations:    
    35. Patti AM, Carruba G, Cicero AFG, Banach M, Nikolic D, Giglio RV, Terranova A, Soresi M, Giannitrapani L, Montalto G, Stoian AP, Banerjee Y, Rizvi AA, Toth PP, Rizzo M, Patti AM, Carruba G, Cicero AFG, Banach M, Nikolic D, Giglio RV, Terranova A, Soresi M, Giannitrapani L, Montalto G, Stoian AP, Banerjee Y, Rizvi AA, Toth PP, Rizzo M. Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study. Metabolites. 2020 Oct 02; 10(10). PMID: 33023123; PMCID: PMC7601817.
      Citations:    
    36. Giglio RV, Nikolic D, Volti GL, Stoian AP, Banerjee Y, Magan-Fernandez A, Castellino G, Patti AM, Chianetta R, Castracani CC, Montalto G, Rizvi AA, Sesti G, Rizzo M, Giglio RV, Nikolic D, Volti GL, Stoian AP, Banerjee Y, Magan-Fernandez A, Castellino G, Patti AM, Chianetta R, Castracani CC, Montalto G, Rizvi AA, Sesti G, Rizzo M. Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect. Metabolites. 2020 Sep 30; 10(10). PMID: 33008044; PMCID: PMC7599907.
      Citations:    
    37. Sachinidis A, Nikolic D, Stoian AP, Papanas N, Tarar O, Rizvi AA, Rizzo M, Sachinidis A, Nikolic D, Stoian AP, Papanas N, Tarar O, Rizvi AA, Rizzo M. Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors. Metabolism. 2020 10; 111:154343. PMID: 32810485.
      Citations:    
    38. Stoian AP, Papanas N, Prazny M, Rizvi AA, Rizzo M, Stoian AP, Papanas N, Prazny M, Rizvi AA, Rizzo M. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. J Cardiovasc Pharmacol Ther. 2020 11; 25(6):494-496. PMID: 32618198.
      Citations:    
    39. Stoian AP, Sachinidis A, Stoica RA, Nikolic D, Patti AM, Rizvi AA, Stoian AP, Sachinidis A, Stoica RA, Nikolic D, Patti AM, Rizvi AA. The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes. Metabolism. 2020 08; 109:154295. PMID: 32553739.
      Citations:    
    40. Stoian AP, Banerjee Y, Rizvi AA, Rizzo M, Stoian AP, Banerjee Y, Rizvi AA, Rizzo M. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. Metab Syndr Relat Disord. 2020 05; 18(4):173-175. PMID: 32271125; PMCID: PMC7196360.
      Citations:    
    41. Patti AM, Rizvi AA, Giglio RV, Stoian AP, Ligi D, Mannello F, Patti AM, Rizvi AA, Giglio RV, Stoian AP, Ligi D, Mannello F. Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes. J Clin Med. 2020 Mar 26; 9(4). PMID: 32225082; PMCID: PMC7230245.
      Citations:    
    42. Cianflone D, Rizvi AA, Rizzo M, Cianflone D, Rizvi AA, Rizzo M. Microvascular and macrovascular effects of liraglutide. Int J Cardiol. 2019 07 01; 286:17-18. PMID: 30878237.
      Citations:    
    43. Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M, Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M. Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study. Diabetes Res Clin Pract. 2019 Mar; 149:163-169. PMID: 30759365.
      Citations:    
    44. Patti AM, Giglio RV, Papanas N, Rizzo M, Rizvi AA, Patti AM, Giglio RV, Papanas N, Rizzo M, Rizvi AA. Future perspectives of the pharmacological management of diabetic dyslipidemia. Expert Rev Clin Pharmacol. 2019 Feb; 12(2):129-143. PMID: 30644763.
      Citations:    
    45. Mahboob R, Rizvi AA, Mahboob R, Rizvi AA. VISUAL VIGNETTE. Endocr Pract. 2018 Dec; 24(12):1110. PMID: 30106631.
      Citations:    
    46. Rizzo M, Nikolic D, Patti AM, Mannina C, Montalto G, McAdams BS, Rizvi AA, Cosentino F, Rizzo M, Nikolic D, Patti AM, Mannina C, Montalto G, McAdams BS, Rizvi AA, Cosentino F. GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms. Biochim Biophys Acta Mol Basis Dis. 2018 09; 1864(9 Pt B):2814-2821. PMID: 29778663.
      Citations:    
    47. Rizvi AA, Rizvi AA. Thyroid Dysfunction in Torsades de Pointes. JAMA Intern Med. 2017 11 01; 177(11):1693. PMID: 29114788.
      Citations:    
    48. Rizvi AA, Rizvi AA. ADDRESSING HYPERTENSION IN THE PATIENT WITH TYPE 2 DIABETES MELLITUS: PATHOGENESIS, GOALS, AND THERAPEUTIC APPROACH. Eur Med J Diabetes. 2017 Oct; 5(1):84-92. PMID: 29129996; PMCID: PMC5679430.
      Citations:    
    49. Rizzo M, Rizvi AA, Sesti G, Rizzo M, Rizvi AA, Sesti G. Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes. Diabetes Obes Metab. 2017 05; 19(5):613-614. PMID: 28098425.
      Citations:    
    50. Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G, Li Volti G, Caprio M, Montalto G, Provenzano V, Genovese S, Ceriello A, Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G, Li Volti G, Caprio M, Montalto G, Provenzano V, Genovese S, Ceriello A. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study. Cardiovasc Diabetol. 2016 Dec 03; 15(1):162. PMID: 27912784; PMCID: PMC5135832.
      Citations:    
    51. Rizvi AA, Rizvi AA. TREATMENT OF TYPE 2 DIABETES WITH BIPHASIC INSULIN ANALOGUES. Eur Med J Diabetes. 2016; 4(1):74-83. PMID: 27918600; PMCID: PMC5134918.
      Citations:    
    52. Rizvi AA, Rizvi AA. The evolving role of bariatric surgery in patients with type 1 diabetes and obesity. Integr Obes Diabetes. 2016; 2(2):195-199. PMID: 27398228; PMCID: PMC4936488.
      Citations:    
    53. Toth PP, Patti AM, Nikolic D, Giglio RV, Castellino G, Biancucci T, Geraci F, David S, Montalto G, Rizvi A, Rizzo M, Toth PP, Patti AM, Nikolic D, Giglio RV, Castellino G, Biancucci T, Geraci F, David S, Montalto G, Rizvi A, Rizzo M. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study. Front Pharmacol. 2015; 6:299. PMID: 26779019; PMCID: PMC4702027.
      Citations:    
    54. McAdams BH, Rizvi AA, McAdams BH, Rizvi AA. An Overview of Insulin Pumps and Glucose Sensors for the Generalist. J Clin Med. 2016 Jan 04; 5(1). PMID: 26742082; PMCID: PMC4730130.
      Citations:    
    55. Rizvi AA, Brennan JR, Rizvi AA, Brennan JR. Giant Intracranial Aneurysm Masquerading in the Sella. Am J Med Sci. 2016 Jan; 351(1):119. PMID: 26802768.
      Citations:    
    56. Nikolic D, Al-Rasadi K, Al Busaidi N, Al-Waili K, Banerjee Y, Al-Hashmi K, Montalto G, Rizvi AA, Rizzo M, Al-Dughaishi T, Nikolic D, Al-Rasadi K, Al Busaidi N, Al-Waili K, Banerjee Y, Al-Hashmi K, Montalto G, Rizvi AA, Rizzo M, Al-Dughaishi T. Incretins, Pregnancy, and Gestational Diabetes. Curr Pharm Biotechnol. 2016; 17(7):597-602. PMID: 26813306.
      Citations:    
    57. Hoppmann RA, Rao VV, Bell F, Poston MB, Howe DB, Riffle S, Harris S, Riley R, McMahon C, Wilson LB, Blanck E, Richeson NA, Thomas LK, Hartman C, Neuffer FH, Keisler BD, Sims KM, Garber MD, Shuler CO, Blaivas M, Chillag SA, Wagner M, Barron K, Davis D, Wells JR, Kenney DJ, Hall JW, Bornemann PH, Schrift D, Hunt PS, Owens WB, Smith RS, Jackson AG, Hagon K, Wilson SP, Fowler SD, Catroppo JF, Rizvi AA, Powell CK, Cook T, Brown E, Navarro FA, Thornhill J, Burgis J, Jennings WR, McCallum JB, Nottingham JM, Kreiner J, Haddad R, Augustine JR, Pedigo NW, Catalana PV, Hoppmann RA, Rao VV, Bell F, Poston MB, Howe DB, Riffle S, Harris S, Riley R, McMahon C, Wilson LB, Blanck E, Richeson NA, Thomas LK, Hartman C, Neuffer FH, Keisler BD, Sims KM, Garber MD, Shuler CO, Blaivas M, Chillag SA, Wagner M, Barron K, Davis D, Wells JR, Kenney DJ, Hall JW, Bornemann PH, Schrift D, Hunt PS, Owens WB, Smith RS, Jackson AG, Hagon K, Wilson SP, Fowler SD, Catroppo JF, Rizvi AA, Powell CK, Cook T, Brown E, Navarro FA, Thornhill J, Burgis J, Jennings WR, McCallum JB, Nottingham JM, Kreiner J, Haddad R, Augustine JR, Pedigo NW, Catalana PV. The evolution of an integrated ultrasound curriculum (iUSC) for medical students: 9-year experience. Crit Ultrasound J. 2015 Dec; 7(1):18. PMID: 26589313; PMCID: PMC4654731.
      Citations:    
    58. Rizvi AA, Patti AM, Giglio RV, Nikolic D, Amato A, Al-Busaidi N, Al-Rasadi K, Soresi M, Banach M, Montalto G, Rizzo M, Rizvi AA, Patti AM, Giglio RV, Nikolic D, Amato A, Al-Busaidi N, Al-Rasadi K, Soresi M, Banach M, Montalto G, Rizzo M. Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study. Expert Opin Biol Ther. 2015; 15(10):1391-7. PMID: 26195184.
      Citations:    
    59. Machado MC, Bruce-Mensah A, Whitmire M, Rizvi AA, Machado MC, Bruce-Mensah A, Whitmire M, Rizvi AA. Hypercalcemia Associated with Calcium Supplement Use: Prevalence and Characteristics in Hospitalized Patients. J Clin Med. 2015 Mar 09; 4(3):414-24. PMID: 26239247; PMCID: PMC4470136.
      Citations:    
    60. Rizzo M, Al-Busaidi N, Rizvi AA, Rizzo M, Al-Busaidi N, Rizvi AA. Dapagliflozin therapy in type-2 diabetes: current knowledge and future perspectives. Expert Opin Pharmacother. 2015 Feb; 16(3):281-4. PMID: 25516459.
      Citations:    
    61. Rizzo M, Abate N, Chandalia M, Rizvi AA, Giglio RV, Nikolic D, Marino Gammazza A, Barbagallo I, Isenovic ER, Banach M, Montalto G, Li Volti G, Rizzo M, Abate N, Chandalia M, Rizvi AA, Giglio RV, Nikolic D, Marino Gammazza A, Barbagallo I, Isenovic ER, Banach M, Montalto G, Li Volti G. Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study. J Clin Endocrinol Metab. 2015 Feb; 100(2):603-6. PMID: 25393640; PMCID: PMC4318909.
      Citations:    
    62. Tripathi A, Liese AD, Winniford MD, Jerrell JM, Albrecht H, Rizvi AA, Zhang J, Duffus WA, Tripathi A, Liese AD, Winniford MD, Jerrell JM, Albrecht H, Rizvi AA, Zhang J, Duffus WA. Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults. Clin Cardiol. 2014 Sep; 37(9):517-22. PMID: 25223811; PMCID: PMC6649542.
      Citations:    
    63. Rizzo M, Chandalia M, Patti AM, Di Bartolo V, Rizvi AA, Montalto G, Abate N, Rizzo M, Chandalia M, Patti AM, Di Bartolo V, Rizvi AA, Montalto G, Abate N. Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. Cardiovasc Diabetol. 2014 Feb 22; 13:49. PMID: 24559258; PMCID: PMC3948058.
      Citations:    
    64. Williams E, Chillag S, Rizvi A, Williams E, Chillag S, Rizvi A. Thyroid bruit and the underlying 'inferno'. Am J Med. 2014 Jun; 127(6):489-90. PMID: 24447837.
      Citations:    
    65. Rizvi AA, Cuadra S, Nikolic D, Giglio RV, Montalto G, Rizzo M, Rizvi AA, Cuadra S, Nikolic D, Giglio RV, Montalto G, Rizzo M. Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association? Curr Pharm Biotechnol. 2014; 15(1):38-46. PMID: 24720595.
      Citations:    
    66. Rizzo M, Obradovic M, Labudovic-Borovic M, Nikolic D, Montalto G, Rizvi AA, Mikhailidis DP, Isenovic ER, Rizzo M, Obradovic M, Labudovic-Borovic M, Nikolic D, Montalto G, Rizvi AA, Mikhailidis DP, Isenovic ER. Uric acid metabolism in pre-hypertension and the metabolic syndrome. Curr Vasc Pharmacol. 2014; 12(4):572-85. PMID: 23627979.
      Citations:    
    67. Rizzo M, Nikolic D, Banach M, Patti AM, Montalto G, Rizvi AA, Rizzo M, Nikolic D, Banach M, Patti AM, Montalto G, Rizvi AA. Incretin-based therapies, glucometabolic health and endovascular inflammation. Curr Pharm Des. 2014; 20(31):4953-60. PMID: 24320037.
      Citations:    
    68. Huggins EA, Chillag SA, Rizvi AA, Moran RR, Durkin MW, Huggins EA, Chillag SA, Rizvi AA, Moran RR, Durkin MW. Diabetic ketoalkalosis in children and adults. South Med J. 2014 Jan; 107(1):6-10. PMID: 24389778.
      Citations:    
    69. Rizvi AA, Nikolic D, Sallam HS, Montalto G, Rizzo M, Abate N, Rizvi AA, Nikolic D, Sallam HS, Montalto G, Rizzo M, Abate N. Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. Metab Syndr Relat Disord. 2014 Feb; 12(1):1-10. PMID: 24206170.
      Citations:    
    70. Brener SJ, Kereiakes DJ, Simonton CA, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Smith RS, Ying SW, Cutlip DE, Stone GW, Brener SJ, Kereiakes DJ, Simonton CA, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Smith RS, Ying SW, Cutlip DE, Stone GW. Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial. Am Heart J. 2013 Dec; 166(6):1035-42. PMID: 24268218.
      Citations:    
    71. Dangas GD, Serruys PW, Kereiakes DJ, Hermiller J, Rizvi A, Newman W, Sudhir K, Smith RS, Cao S, Theodoropoulos K, Cutlip DE, Lansky AJ, Stone GW, Dangas GD, Serruys PW, Kereiakes DJ, Hermiller J, Rizvi A, Newman W, Sudhir K, Smith RS, Cao S, Theodoropoulos K, Cutlip DE, Lansky AJ, Stone GW. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2013 Sep; 6(9):914-22. PMID: 24050859.
      Citations:    
    72. Machado MC, Rizvi AA, Machado MC, Rizvi AA. The "calcium supplement syndrome": modern-day reemergence of a bygone disorder. J S C Med Assoc. 2013 Sep; 109(3):88-91. PMID: 24261156.
      Citations:    
    73. Tripathi A, Jerrell JM, Liese AD, Zhang J, Rizvi AA, Albrecht H, Duffus WA, Tripathi A, Jerrell JM, Liese AD, Zhang J, Rizvi AA, Albrecht H, Duffus WA. Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011. Metab Syndr Relat Disord. 2013 Dec; 11(6):417-26. PMID: 23909647.
      Citations:    
    74. Aziz S, Rizvi A, Aziz S, Rizvi A. Thyrotoxicosis and neck pain: getting the right test at the right time. Am J Med. 2013 Aug; 126(8):e7-8. PMID: 23795896.
      Citations:    
    75. Rizzo M, Avogaro A, Montalto G, Rizvi AA, Rizzo M, Avogaro A, Montalto G, Rizvi AA. Non-glycemic effects of pioglitazone and incretin-based therapies. Expert Opin Ther Targets. 2013 Jul; 17(7):739-42. PMID: 23691979.
      Citations:    
    76. Rizzo M, Rizvi AA, Sudar E, Soskic S, Obradovic M, Montalto G, Boutjdir M, Mikhailidis DP, Isenovic ER, Rizzo M, Rizvi AA, Sudar E, Soskic S, Obradovic M, Montalto G, Boutjdir M, Mikhailidis DP, Isenovic ER. A review of the cardiovascular and anti-atherogenic effects of ghrelin. Curr Pharm Des. 2013; 19(27):4953-63. PMID: 23278489.
      Citations:    
    77. Rizzo M, Barylski M, Rizvi AA, Montalto G, Mikhailidis DP, Banach M, Rizzo M, Barylski M, Rizvi AA, Montalto G, Mikhailidis DP, Banach M. Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia? Curr Pharm Des. 2013; 19(21):3858-68. PMID: 23286436.
      Citations:    
    78. Aziz SA, Singer MC, Terris DJ, Rizvi AA, Aziz SA, Singer MC, Terris DJ, Rizvi AA. Visual vignette. Endocr Pract. 2012 Nov-Dec; 18(6):1039. PMID: 22784852.
      Citations:    
    79. Tripathi A, Rizvi AA, Knight LM, Jerrell JM, Tripathi A, Rizvi AA, Knight LM, Jerrell JM. Prevalence and impact of initial misclassification of pediatric type 1 diabetes mellitus. South Med J. 2012 Oct; 105(10):513-7. PMID: 23038480.
      Citations:    
    80. Rizvi AA, Montalto G, Patti AM, Rizzo M, Rizvi AA, Montalto G, Patti AM, Rizzo M. Oxidative stress and small, dense low-density lipoproteins: current and future perspectives. Expert Rev Endocrinol Metab. 2012 Jul; 7(4):415-417. PMID: 30754159.
      Citations:    
    81. Hermiller JB, Sudhir K, Applegate RJ, Rizvi A, Wang J, Gordon PC, Yaqub M, Cao S, Ferguson JM, Smith RS, Sood P, Stone GW, Hermiller JB, Sudhir K, Applegate RJ, Rizvi A, Wang J, Gordon PC, Yaqub M, Cao S, Ferguson JM, Smith RS, Sood P, Stone GW. Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials. EuroIntervention. 2012 May 15; 8(1):87-93. PMID: 22580252.
      Citations:    
    82. Aamir S, Rizvi AA, Aamir S, Rizvi AA. Visual vignette. Suppurative thyroiditis due to Nocardia asteroides. Endocr Pract. 2012 May-Jun; 18(3):426. PMID: 22592052.
      Citations:    
    83. Rizzo M, Montalto G, Rizvi AA, Christ ER, Rizzo M, Montalto G, Rizvi AA, Christ ER. The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly. Angiology. 2012 Oct; 63(7):492-4. PMID: 22371625.
      Citations:    
    84. Shlapack MA, Rizvi AA, Lopez FA, Shlapack MA, Rizvi AA, Lopez FA. Normocalcemic primary hyperparathyroidism-characteristics and clinical significance of an emerging entity. Am J Med Sci. 2012 Feb; 343(2):163-166. PMID: 22173046.
      Citations:    
    85. Jerrell JM, Tripathi A, Rizvi AA, McIntyre RS, Jerrell JM, Tripathi A, Rizvi AA, McIntyre RS. The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis. Prim Care Companion CNS Disord. 2012; 14(1). PMID: 22690363; PMCID: PMC3357575.
      Citations:    
    86. Tonda C, Rizvi AA, Tonda C, Rizvi AA. Headache, pituitary lesion and panhypopituitarism in a pregnant woman: tumor, apoplexy or hypophysitis? Am J Med Sci. 2011 Sep; 342(3):247-9. PMID: 21681070.
      Citations:    
    87. Patel R, Rizvi AA, Patel R, Rizvi AA. Vitamin D deficiency in patients with congestive heart failure: mechanisms, manifestations, and management. South Med J. 2011 May; 104(5):325-30. PMID: 21606710.
      Citations:    
    88. Rizvi AA, Rizvi AA. Hypertension, obesity, and inflammation: the complex designs of a deadly trio. Metab Syndr Relat Disord. 2010 Aug; 8(4):287-94. PMID: 20367224.
      Citations:    
    89. Rizvi AA, Chillag SA, Chillag KJ, Rizvi AA, Chillag SA, Chillag KJ. Perioperative management of diabetes and hyperglycemia in patients undergoing orthopaedic surgery. J Am Acad Orthop Surg. 2010 Jul; 18(7):426-35. PMID: 20595135.
      Citations:    
    90. Butler C, Butler WM, Rizvi AA, Butler C, Butler WM, Rizvi AA. Sustained remission with the kinase inhibitor sorafenib in stage IV metastatic adrenocortical carcinoma. Endocr Pract. 2010 May-Jun; 16(3):441-5. PMID: 20061282.
      Citations:    
    91. Rizvi AA, Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci. 2009 Oct; 338(4):310-8. PMID: 19726972.
      Citations:    
    92. Rizzo M, Rizvi AA, Spinas GA, Rini GB, Berneis K, Rizzo M, Rizvi AA, Spinas GA, Rini GB, Berneis K. Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors. Expert Opin Investig Drugs. 2009 Oct; 18(10):1495-503. PMID: 19758106.
      Citations:    
    93. Rizvi AA, McLaughlin N, Rizvi AA, McLaughlin N. Impact of comprehensive diabetes specialty care in the management of older adults with stage 3 or 4 nephropathy. South Med J. 2009 Sep; 102(9):985. PMID: 19668037.
      Citations:    
    94. Rizzo M, Rizvi AA, Rini GB, Berneis K, Rizzo M, Rizvi AA, Rini GB, Berneis K. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetol. 2009 Mar; 46(1):1-11. PMID: 18925358.
      Citations:    
    95. Narasimhan K, Rizvi AA, Narasimhan K, Rizvi AA. Vitamin D levels in patients seen in the diabetes unit of an academic medical center. South Med J. 2008 Oct; 101(10):1069. PMID: 18791513.
      Citations:    
    96. Davis RM, Hitch AD, Nichols M, Rizvi A, Salaam M, Mayer-Davis EJ, Davis RM, Hitch AD, Nichols M, Rizvi A, Salaam M, Mayer-Davis EJ. A collaborative approach to the recruitment and retention of minority patients with diabetes in rural community health centers. Contemp Clin Trials. 2009 Jan; 30(1):63-70. PMID: 18824135.
      Citations:    
    97. Rizvi AA, Rizvi AA. 46, XX man with SRY gene translocation: cytogenetic characteristics, clinical features and management. Am J Med Sci. 2008 Apr; 335(4):307-9. PMID: 18414071.
      Citations:    
    98. Rizvi AA, Rizvi AA. Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome. Chin Med J (Engl). 2007 Nov 05; 120(21):1918-24. PMID: 18067768.
      Citations:    
    99. Rizvi AA, Rizvi AA. "Thyrotoxic psychosis" associated with subacute thyroiditis. South Med J. 2007 Aug; 100(8):837-40. PMID: 17713314.
      Citations:    
    100. Rizvi AA, Rizvi AA. Care of patients with diabetes who are undergoing surgery. JAAPA. 2007 Apr; 20(4):36, 38, 41-2 passim. PMID: 17484330.
      Citations:    
    101. Rizvi AA, Lockwood A, Moonan AT, Strong DS, Rizvi AA, Lockwood A, Moonan AT, Strong DS. Development, implementation and preliminary results of the Diabetes Chronic Disease Management Collaborative in South Carolina. J S C Med Assoc. 2007 Apr; 103(3):54-9. PMID: 18189073.
      Citations:    
    102. Rizvi AA, Rizvi AA. Management of diabetes in older adults. Am J Med Sci. 2007 Jan; 333(1):35-47. PMID: 17220692.
      Citations:    
    103. Sonnier CS, Rizvi AA, Sonnier CS, Rizvi AA. Parasellar meningioma resembling a pituitary tumor. Endocr Pract. 2007 Jan-Feb; 13(1):86-8. PMID: 17360308.
      Citations:    
    104. Wang S, Rizvi AA, Wang S, Rizvi AA. Levofloxacin-induced hypoglycemia in a nondiabetic patient. Am J Med Sci. 2006 Jun; 331(6):334-5. PMID: 16775443.
      Citations:    
    105. Schenck JB, Rizvi AA, Lin T, Schenck JB, Rizvi AA, Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci. 2006 Mar; 331(3):154-6. PMID: 16538077.
      Citations:    
    106. Rizvi AA, Sanders MB, Rizvi AA, Sanders MB. Assessment and monitoring of glycemic control in primary diabetes care: monitoring techniques, record keeping, meter downloads, tests of average glycemia, and point-of-care evaluation. J Am Acad Nurse Pract. 2006 Jan; 18(1):11-21. PMID: 16403208.
      Citations:    
    107. Rizvi AA, Rizvi AA. The role of inflammation in diabetes and its complications. South Med J. 2006 Jan; 99(1):8-9. PMID: 16466109.
      Citations:    
    108. Rizvi AA, Rizvi AA. Current trends in diabetes management. JAAPA. 2005 Aug; 18(8):23-9. PMID: 16119012.
      Citations:    
    109. Tandon PK, Rizvi AA, Tandon PK, Rizvi AA. Hypocalcemia and parathyroid function in metastatic prostate cancer. Endocr Pract. 2005 Jul-Aug; 11(4):254-8. PMID: 16006299.
      Citations:    
    110. Rizvi AA, Rizvi AA. Type 2 diabetes: epidemiologic trends, evolving pathogenetic [corrected] concepts, and recent changes in therapeutic approach. South Med J. 2004 Nov; 97(11):1079-87. PMID: 15586598.
      Citations:    
    111. Rizvi AA, Rizvi AA. Some clues and pitfalls in the diagnosis of acromegaly. Endocr Pract. 2004 Jul-Aug; 10(4):348-52. PMID: 15760780.
      Citations:    
    112. Rizvi AA, Rizvi AA. Recognition and implications of the metabolic syndrome. J S C Med Assoc. 2004 Apr; 100(4):107-12. PMID: 15162668.
      Citations:    
    113. Rizvi AA, Bowman MA, Vaughters RB, Isales C, Mulloy AL, Rizvi AA, Bowman MA, Vaughters RB, Isales C, Mulloy AL. Primary ovarian lymphoma manifesting with severe hypercalcemia. Endocr Pract. 2003 Sep-Oct; 9(5):389-93. PMID: 14583422.
      Citations: 2     Fields:    Translation:Humans
    114. Rizvi AA, Bowman MA, Rizvi AA, Bowman MA. Thiazolidinedione therapy in a patient with diabetes after cardiac transplantation. Endocr Pract. 2002 Jul-Aug; 8(4):287-91. PMID: 12173915.
      Citations:    Fields:    Translation:Humans
    Rizvi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (345)
    Explore
    _
    Co-Authors (17)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _